Only Eye Vitamin That Supports Two Health Benefits in One, Clinically Proven AREDS 2 Formula for Eye Health and 100 mg of CoQ10 Antioxidant for Heart Health*VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb
Program seeks to increase neuroimaging clinical research and knowledge transfer between high-income and low- and medium-income countriesTORONTO--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the S
- C$70M in potential funding through a combination of the previously announced common share purchase agreement and current “at-the-market” equity program helps support upcoming clinical milestones - - Topline clinical data readouts expected in late Q
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate in
Findings from the ongoing Phase 1 MYTHIC study demonstrated a favorable and distinctive tolerability profile for monotherapy lunresertib Monotherapy antitumor activity observed, including confirmed partial response and several patients with long stable d
Vizgen Intends to Aggressively Defend Pioneering MERSCOPE Technology in Europe Just as it has in the U.S. Previous 10x Judgments Versus Competitors Have No Application to Vizgen CasesCAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc. (“Vizgen” or the
SASKATOON, Saskatchewan--(BUSINESS WIRE)--#agriculture--Ag-West Bio is pleased to announce that the 2018 to 2023 Diverse Field Crops Cluster (DFCC) Research Report is now available. Over the past five years, scientists across Canada have been working on 1
This year’s GreenTech, one of the world’s leading horticulture events, includes speaking sessions featuring Fluence experts and the launch of Fluence’s newest VYPR productAUSTIN, Texas & ROTTERDAM, Netherlands--(BUSINESS WIRE)--Fluence, a leading g
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is p
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addic
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.